OA01363A - Procédé de préparation de dérivés de diphényl-méthane portant des substituants basiques. - Google Patents

Procédé de préparation de dérivés de diphényl-méthane portant des substituants basiques.

Info

Publication number
OA01363A
OA01363A OA51809A OA51809A OA01363A OA 01363 A OA01363 A OA 01363A OA 51809 A OA51809 A OA 51809A OA 51809 A OA51809 A OA 51809A OA 01363 A OA01363 A OA 01363A
Authority
OA
OAPI
Prior art keywords
diphenyl
preparation
methane derivatives
derivatives bearing
basic substituents
Prior art date
Application number
OA51809A
Other languages
English (en)
French (fr)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of OA01363A publication Critical patent/OA01363A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
OA51809A 1958-05-07 1964-12-31 Procédé de préparation de dérivés de diphényl-méthane portant des substituants basiques. OA01363A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEF25702A DE1111642B (de) 1958-05-07 1958-05-07 Verfahren zur Herstellung von basisch substituierten Diphenylmethan-Derivaten mit Herz- und Kreislaufwirksamkeit

Publications (1)

Publication Number Publication Date
OA01363A true OA01363A (fr) 1969-07-04

Family

ID=7091732

Family Applications (1)

Application Number Title Priority Date Filing Date
OA51809A OA01363A (fr) 1958-05-07 1964-12-31 Procédé de préparation de dérivés de diphényl-méthane portant des substituants basiques.

Country Status (10)

Country Link
US (1) US3152173A (xx)
BE (1) BE578515A (xx)
CH (8) CH388329A (xx)
CY (1) CY277A (xx)
DE (1) DE1111642B (xx)
FR (1) FR553M (xx)
GB (1) GB916644A (xx)
MY (1) MY6400049A (xx)
NL (2) NL238796A (xx)
OA (1) OA01363A (xx)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3262977A (en) * 1962-03-10 1966-07-26 Chinoin Gyogyszer Es Vegyeszet N-aralkyl-1, 1-diphenyl-propylamine derivatives
NL296693A (xx) * 1962-08-16
FR95908E (fr) * 1963-11-09 1972-01-31 Degussa Procédé de préparation de nouvelles aminocétones et des alcools secondaires correspondants.
US3457354A (en) * 1965-09-21 1969-07-22 Merck & Co Inc Treatment of hypertension with 2-hydroxy (or amino) - 4,5 - dihydroxyphenethylamine derivatives
US3895057A (en) * 1967-10-13 1975-07-15 Dainippon Pharmaceutical Co Aminoalkanols and their pharmaceutically acceptable acid-addition salts, and production thereof
US4329367A (en) * 1974-08-05 1982-05-11 Ciba-Geigy Corporation 1-(Aralkoxyphenyl)-2-(bis-arylalkylamino)-alkanes
DE2902172C2 (de) * 1979-01-20 1984-05-10 UOP Inc., 60016 Des Plaines, Ill. Verfahren zur Herstellung eines N,N'-Dialkylphenylendiamins
JPS59500764A (ja) * 1982-04-23 1984-05-04 カオラ　コズメテイカイ　エス　ハズタルタスベジパリ　バララト プレニルアミン含有化粧品組成物
AU592557B2 (en) * 1985-04-16 1990-01-18 F. Hoffmann-La Roche Ag Phenethanolamine derivatives
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
JP2004517919A (ja) * 2001-01-26 2004-06-17 シェーリング　コーポレイション 血管状態の処置のための心臓血管薬剤とステロール吸収インヒビターとの組み合わせ
CA2434488A1 (en) * 2001-01-26 2002-08-01 Harry R. Davis Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
HUP0303915A3 (en) * 2001-01-26 2012-12-28 Merck Sharp & Dohme Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
AR032403A1 (es) * 2001-01-26 2003-11-05 Schering Corp Combinaciones de inhibidor(es) de la absorcion de esterol con modificador(es) sanguineos para tratar cuadros vasculares
KR100820983B1 (ko) * 2001-01-26 2008-04-10 쉐링 코포레이션 치환된 아제티딘온 화합물을 포함하는 약제학적 조성물
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
TW200744638A (en) * 2001-01-26 2007-12-16 Schering Corp Combinations of bile acid sequestrant(s) and sterol absorption inhibitors and treatments for vascular indications
US20030013699A1 (en) * 2001-05-25 2003-01-16 Davis Harry R. Methods for treating alzheimer's disease and/or regulating levels of amyloid beta peptides in a subject
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
DK1429756T3 (da) * 2001-09-21 2007-03-19 Schering Corp Behandling af xanthoma med azetidinonderivater som sterolabsorptionsinhibitorer
EP1427409B1 (en) * 2001-09-21 2008-10-15 Schering Corporation Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s)
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
RS20050106A (xx) 2002-08-19 2007-11-15 Pfizer Products Inc., Kombinovana terapija hiperproliferativnih bolesti
CA2504878A1 (en) * 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorption inhibitors for the treatment of demyelination
US7192944B2 (en) * 2003-03-07 2007-03-20 Schering Corp. Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
ATE406364T1 (de) 2003-03-07 2008-09-15 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
CN1756756A (zh) 2003-03-07 2006-04-05 先灵公司 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
WO2005046797A2 (en) * 2003-11-05 2005-05-26 Schering Corporation Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
CA2574958A1 (en) * 2004-07-26 2006-02-09 Cotherix, Inc. Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
EP2111863B1 (en) 2005-10-26 2012-03-28 Asahi Kasei Pharma Corporation Fasudil in combination with bosentan for the treament of pulmonary arterial hypertension
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2009149279A2 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US8883844B2 (en) 2010-09-24 2014-11-11 Nitrogenix Inc. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
AU2014255381A1 (en) 2013-04-17 2015-10-08 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
CA2913737A1 (en) 2013-06-05 2014-12-11 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase c, method of making and using same
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
MX2021008533A (es) 2019-01-18 2021-08-19 Astrazeneca Ab Inhibidores de la pcsk9 y metodos de uso de los mismos.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2601323A (en) * 1949-02-02 1952-06-24 Upjohn Co Process for preparing 4, 4-diphenyl-6-dimethylamino-heptanone-3
US2681934A (en) * 1950-01-06 1954-06-22 Commercial Solvents Corp Substituted diphenylalkylamines
US2797242A (en) * 1953-08-11 1957-06-25 Parke Davis & Co Substituted alpha-benzylphenethylamines and methods for producing the same
US2738347A (en) * 1954-12-13 1956-03-13 Olin Mathieson Penicillin salt of benzhydryl-phenethylamine
US2872374A (en) * 1955-02-02 1959-02-03 Nat Drug Co Muscle-relaxing tranquilizer compositions
US2894033A (en) * 1955-11-15 1959-07-07 Nl Combinatie Chem Ind Antispasmodic 1, 1-diphenyl-3-dialkylaminopropane, and its tertiary and quaternary salts
US2854379A (en) * 1956-06-06 1958-09-30 Miles Lab Tranquilizing composition comprising 2-ethyl-cis-crotonylurea
DE1058063B (de) * 1957-02-08 1959-05-27 Hoechst Ag Verfahren zur Herstellung von analgetisch wirksamen substituierten Phenylaethylaminen

Also Published As

Publication number Publication date
NL238796A (xx)
MY6400049A (en) 1964-12-31
US3152173A (en) 1964-10-06
GB916644A (en) 1963-01-23
CY277A (en) 1964-02-12
NL108640C (xx)
CH385878A (de) 1964-12-31
BE578515A (xx)
CH388328A (de) 1965-02-28
CH397710A (de) 1965-08-31
FR553M (xx) 1961-05-29
CH396931A (de) 1965-08-15
CH388334A (de) 1965-02-28
CH388329A (de) 1965-02-28
DE1111642B (de) 1961-07-27
CH388332A (de) 1965-02-28
CH388333A (de) 1965-02-28

Similar Documents

Publication Publication Date Title
OA01363A (fr) Procédé de préparation de dérivés de diphényl-méthane portant des substituants basiques.
FR1229384A (fr) Procédé de préparation de dérivés de la 2, 3-dimercapto-quinoxaline
BE589982A (fr) Procédé de préparation de dérivés de la phtalimidine.
BE591486A (fr) Procédé pour la préparation de dérivés de 5-fluoro-cytosine.
BE579237A (fr) Procédé de préparation des phosphoramidates.
FR1292922A (fr) Procédé de préparation de dérivés de diphényl-méthane portant des substituants basiques
FR1309818A (fr) Procédé de préparation de dérivés de 20-alcoyl-amino-stéroïdes
BE583839A (fr) Procédé de préparation de dérivés quinoniques.
FR1238739A (fr) Procédé de préparation de dérivés hydrosolubles de testostérone
FR1481001A (fr) Procédé de préparation des dérivés de la phénacyl-pipérazine
FR1274397A (fr) Procédé de préparation de dérivés 9alpha-fluoro 16alpha-méthyl delta1, 4-pregnadiènes
BE589345A (fr) Procédé de préparation de dérivés phénothiaziniques.
FR1274399A (fr) Procédé perfectionné de préparation de dérivés du 5-nitro-2-formyl-furan
FR1223732A (fr) Procédé de préparation de dérivés 2-thiono-4-hydroxytétrahydropyrimidines
BE577308A (fr) Procédé de préparation de dérivés du thiaxanthène à substituants basiques.
FR1295307A (fr) Procédé de préparation de dérivés cyclopentano-phénanthréniques
FR1404860A (fr) Procédé de préparation de dérivés de la 5-amino-8-hydroxy-1. 4-naphtoquinone-1-imine portant des substituants basiques
FR1294102A (fr) Procédé de préparation des dérivés azotés de phénylalcanols
FR1330109A (fr) Procédé de préparation de dérivés de la dichloro-acétanilide
FR1383702A (fr) Procédé de préparation de dérivés de la disulfamylaniline
CH384582A (fr) Procédé de préparation de dérivés de la dihydrobenzothiadiazine
FR1291508A (fr) Procédé de préparation de dérivés de la dihydro-vitamine k
FR1272913A (fr) Procédé de préparation des 5-alkyl-2-p-halogénobenzènesulfonamido-1, 3, 4-thiadiazoles
FR1298304A (fr) Procédé de préparation de dérivés de la kanamycine
FR1341467A (fr) Procédé de préparation de dérivés de nu-carboxylalcoyl-2-phényléthylamines